专家论坛

肠道微生态干预慢性病发展的新认识

展开
  • 同济大学附属第十人民医院普外科,上海 200072

收稿日期: 2017-11-15

  网络出版日期: 2020-07-25

基金资助

国家自然科学基金(81230057,81372615, 81472 262,81302066,81200264); 上海新兴前沿技术联合攻关项目(SHDC12012106); 同济大学先导项目(162385)

本文引用格式

秦环龙, 孔程 . 肠道微生态干预慢性病发展的新认识[J]. 外科理论与实践, 2018 , 23(01) : 14 -19 . DOI: 10.16139/j.1007-9610.2018.01.004

参考文献

[1] Greenstein JP, Birnbaum SM, Winitz MA.A water-soluble synthetic diet[J]. Arch Biochem Biophys,1956,63(1):266-268.
[2] Wilmore DW, Smith RJ, O′Dwyer ST, et al. The gut: a central organ after surgical stress[J]. Surgery,1988,104(5):917-923.
[3] 黎介寿. 临床营养支持的发展趋势[C]. 2010全国肠外肠内营养学术会议,2010.
[4] 胥欣, 王伟, 曹卉, 等. 活动期与缓解期炎症性肠病患者粪便主要菌群差异分析[J]. 武汉大学学报(医学版),2017,38(4):641-646.
[5] Malinen E, Rinttila T, Kajander K, et al.Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR[J]. Am J Gastroenterol,2005,100(2):373-382.
[6] Nobaek S, Johansson ML, Molin G, et al.Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome[J]. Am J Gastroenterol,2000,95(5):1231-1238.
[7] Niedzielin K, Kordecki H, Birkenfeld B.A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome[J]. Eur J Gastroenterol Hepatol,2001,13(10):1143-1147.
[8] Yang Y, Weng W, Peng J, et al.Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to NFkappaB, upregulating expression of microRNA-21[J]. Gastroenterology,2016,152(4):851-866.
[9] Yang Y, Xia Y, Chen H, et al.The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial[J]. Oncotarget, 2016,7(7):8432-8440.
[10] Everard A, Lazarevic V, Derrien M, et al.Responses of gut microbiota and glucose and lipid metabolism to prebio-tics in genetic obese and diet-induced leptin-resistant mice[J]. Diabetes,2011,60(11):2775-2786.
[11] Angelopoulos N, Goula A, Tolis G.Current knowledge in the neurophysiologic modulation of obesity[J]. Metabolis,2005,54(9):1202-1217.
[12] Eun CS, Han DS, Lee SH, et al.Probiotics may reduce inflammation by enhancing peroxisome proliferator activated receptor gamma activation in HT-29 cells[J]. Korean J Gastroenterol,2007,49(3):139-146.
[13] Wang Z, Klipfell E, Bennett BJ, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature,2011,472(7341):57-63.
[14] Wang Z, Roberts AB, Buffa JA, et al.Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell,2015,163(7):1585-1595.
[15] Harach T, Marungruang N, Duthilleul N, et al.Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota[J]. Sci Rep,2017,7:41802.
[16] Akbari E, Asemi Z, Daneshvar Kakhaki R, et al.Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer′s disease: a randomized, double-blind and controlled trial[J]. Front Aging Neurosci,2016,8:256.
[17] Tang AT, Choi JP, Kotzin JJ, et al.Endothelial TLR4 and the microbiome drive cerebral cavernous malformations[J]. Nature,2017,545(7654):305-310.
[18] Ge X, Tian H, Ding C, et al.Fecal microbiota transplantation in combination with soluble dietary fiber for treatment of slow transit constipation: a pilot study[J]. Arch Med Res,2016,47(3):236-242.
[19] Moayyedi P, Surette MG, Kim PT, et al.Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial[J]. Gastroenterology,2015,149(1):102-109.
[20] Benus RF, van der Werf TS, Welling GW, et al. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects[J]. Br J Nutr,2010,104(5):693-700.
[21] Ruemmele FM, Veres G, Kolho KL, et al.Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn′s disease[J]. J Crohns Colitis,2014,8(10):1179-1207.
[22] Gerritsen J, Timmerman HM, Fuentes S, et al.Correlation between protection against sepsis by probiotic therapy and stimulation of a novel bacterial phylotype[J]. Appl Environ Microbiol,2011,77(21):7749-7756.
[23] Tan C, Ling Z, Huang Y, et al.Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis[J]. Pancreas,2015,44(6):868-875.
[24] Donaldson GP, Lee SM, Mazmanian SK.Gut biogeography of the bacterial microbiota[J]. Nat Rev Microbiol,2016,14(1):20-32.
[25] Zhao Y, Jaber V, Lukiw WJ.Secretory products of the human GI tract microbiome and their potential impact on Alzheimer′s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus[J]. Front Cell Infect Microbiol,2017,7:318.
[26] 张锦涛, 伊曼, 李志嘉, 等. 丁酸盐在炎症反应中作用机制的研究进展[J]. 免疫学杂志,2015,31(12):1101-1104.
[27] Mollet B.Genetically improved starter strains: opportunities for the dairy industry[J]. Int Dairy J,1999,9(1):11-15.
[28] 李琳, 赵谋明. 益生菌的安全性及基因改造[J]. 中国乳品工业,2005,33(6):43-46.
文章导航

/